by October Gallery
PARIS (Reuters) – France’s health watchdog on Friday recommended that social security stop reimbursing patients for homeopathic drugs, citing insufficient effectiveness. For nine months the HAS watchdog investigated the effects…
(Reuters) – Teleflex Inc said on Monday it plans to recall some lots of its Hudson RCI Sheridan endotracheal tubes used for helping patients breathe, following reports of four deaths.…
(Reuters) – Japan’s Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its drug quizartinib as a treatment for adults with a type…
ZURICH (Reuters) – A U.S. group that reviews the value of medicines issued a critical report on Novartis’s new multiple sclerosis drug Mayzent, calling its $88,561 list price “far out…
(Reuters) – The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in premenopausal women, the latest attempt to come up with a…
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon…
TEL AVIV (Reuters) – Zebra Medical Vision, an Israel medical imaging analytics company, said on Monday it received its third clearance from the U.S. Food and Drug Administration for its…
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe…
FILE PHOTO: Cannabis plants fill a room in an aquaponics grow operation by licensed marijuana producer Green Relief in Flamborough, Ontario, Canada January 25, 2019. Picture taken January 25, 2019.…
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (This June 10 story deletes paragraph 9 to clarify…